Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
In: Journal of Clinical Oncology, Jg. 32 (2014-04-20), Heft 12, S. 1188-1194
academicJournal
Zugriff:
Titel: |
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
|
---|---|
Autor/in / Beteiligte Person: | Raemaekers, John M M ; André, Marc P E ; Federico, Massimo ; Girinsky, Theodore ; Oumedaly, Reman ; Brusamolino, Ercole ; Brice, Pauline ; Fermé, Christophe ; van der Maazen, Richard ; Gotti, Manuel ; Bouabdallah, Reda ; Sebban, Catherine J ; Lievens, Yolande ; Re, Allessandro ; Stamatoullas, Aspasia ; Morschhauser, Frank ; Lugtenburg, Pieternella J ; Abruzzese, Elisabetta ; Olivier, Pierre ; Casasnovas, Rene-Olivier |
Zeitschrift: | Journal of Clinical Oncology, Jg. 32 (2014-04-20), Heft 12, S. 1188-1194 |
Veröffentlichung: | 2014 |
Medientyp: | academicJournal |
ISSN: | 0732-183X (print) |
DOI: | 10.1200/JCO.2013.51.9298 |
Sonstiges: |
|